+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Angiography Imaging Systems - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2027-2032)

  • PDF Icon

    Report

  • 180 Pages
  • November 2026
  • Region: Global
  • Mordor Intelligence
  • ID: 6294575
The angiography imaging systems market size is projected to expand from USD 18.02 billion in 2026 and USD 19.27 billion in 2027 to USD 26.05 billion by 2032, registering a CAGR of 6.21% between 2027 and 2032. This report is Segmented by Technology (X-Ray Angiography, CT Angiography, MRI Angiography, MR-CT Angiography), Application (Cardiology, Oncology, Neurology, and More), End-User (Hospitals, Ambulatory Surgical Centers, Diagnostic Centers, and More), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, South America). The Market Forecasts are Provided in Terms of Value (USD).

Global Angiography Imaging Systems Market Trends and Insights

Rising Cardiovascular and Cerebrovascular Disease Burden

Cardiovascular disease continues to widen the clinical base that requires vascular diagnosis and intervention. The World Health Organization states that cardiovascular diseases caused 32% of deaths globally, which keeps coronary and vascular care central to hospital planning. The angiography imaging systems market, therefore, benefits from recurring imaging needs across coronary disease, stroke, and aneurysm care. Growing cerebrovascular care needs in APAC can raise demand for biplane neuroradiology suites, which support complex neurological procedures. Those systems carry a higher average selling price than single-plane cardiac installations. The mix of coronary and neurological cases also raises the importance of imaging quality, workflow speed, and reliable access to specialized staff.

Migration Toward Minimally Invasive Image-Guided Procedures

Catheter-based treatment is reducing the need for open procedures across cardiology, oncology, and neurology. This shift broadens the case base for the angiography imaging systems market for real-time angiographic guidance and supports the utilization of installed systems. TACE and SIRT require angiographic guidance and remain relevant to liver-directed cancer treatment. Expanded thrombectomy eligibility windows can increase the number of procedures handled by stroke-certified centers. Structural heart procedures, including transcatheter aortic valve replacement and WATCHMAN closure, require cone-beam CT capability and 3D roadmapping software. These requirements can shorten replacement cycles because older flat-panel platforms may not support complex and higher-value procedures.

High Capital, Service, and Room-Conversion Costs

The cost structure of the angiography imaging systems market extends beyond the equipment purchase price beyond the equipment purchase price. Shielding, HVAC work, RIS and PACS integration, and commissioning can add 30% to 50% to acquisition costs. This burden is most difficult for public hospitals in MEA and Latin America with constrained capital budgets. Service agreements are also necessary for software-dependent systems and add recurring costs that some procurement structures cannot absorb. The most AI-capable platforms can carry the greatest service obligations, restricting access to private chains and academic medical centers. Compliance with IEC 60601-1 and national radiation protection rules can add further commissioning requirements before a system is used.

Other drivers and restraints analyzed in the detailed report include:

  1. AI-Enabled Image Reconstruction and Dose Optimization
  2. Expansion of Hybrid Operating Rooms and Advanced Cath Labs
  3. Radiation Exposure and Contrast-Related Clinical Risks

Segment Analysis

X-ray angiography held 39.52% of the angiography imaging systems market share in 2026. Its position reflects its established use in cardiac catheterization, PCI guidance, and real-time fluoroscopic visualization of coronary anatomy. Digital subtraction angiography retains strong temporal resolution for these procedures. CT angiography remains important for emergency vascular assessment, including aortic dissection, pulmonary embolism, and peripheral runoff. Multi-detector systems can complete aortoiliac surveys in less than 10 seconds. The angiography imaging systems market continues to rely on X-ray systems, where an intervention must be guided in real time.

MRI angiography is forecasted to grow at 7.26% CAGR through 2032. Non-contrast MRA is gaining use in neurology, renal artery assessment, and pediatric vascular imaging. These applications prioritize the avoidance of ionizing radiation. The technique can also reduce dependence on gadolinium-based contrast agents. It can broaden vascular assessment for patients with renal insufficiency who may not be suitable for contrast-enhanced studies. MR-CT Angiography remains the smallest technology group.

Complete Report Scope:

  • By Technology
    • X-Ray Angiography
    • CT Angiography
    • MRI Angiography
    • MR-CT Angiography
  • By Application
    • Cardiology
    • Oncology
    • Neurology
    • Peripheral and Vascular Intervention
    • Other Applications
  • By End-User
    • Hospitals
    • Ambulatory Surgical Centers
    • Diagnostic Centers
    • Other End-Users
  • By Geography
    • North America
      • United States
      • Canada
      • Mexico
    • Europe
      • Germany
      • United Kingdom
      • France
      • Italy
      • Spain
      • Rest of Europe
    • Asia-Pacific
      • China
      • Japan
      • India
      • Australia
      • South Korea
      • Rest of Asia-Pacific
    • Middle East and Africa
      • GCC
      • South Africa
      • Rest of Middle East and Africa
    • South America
      • Brazil
      • Argentina
      • Rest of South America

Geography Analysis

North America held 46.12% of the angiography imaging systems market share in 2026. The region benefits from a dense network of catheterization laboratories, high per-capita PCI activity, and reimbursement structures that support advanced imaging investment. GE HealthCare received FDA 510(k) clearance and CE Mark for Allia Moveo in February 2026. Canon Medical also received FDA 510(k) clearance for Alphenix 4D CT in November 2025. These clearances support near-term modernization at cardiovascular centers. Canada has cath lab upgrade activity for aging populations, while private hospital expansion supports early demand in Mexico. The United States also provides reference sites for hybrid operating room models.

Europe is the second-largest regional segment for the angiography imaging systems market. Germany, the United Kingdom, and France accounted for 61% of regional interventional imaging demand in that research. The figure on annual procedures and the reported 2024 to 2025 adoption rate were excluded because their cited source was not eligible. Europe has procurement requirements under the EU Medical Device Regulation and IEC 60601 safety standards. Romania's Ponderas Academic Hospital invested EUR 1.7 million (USD 1.9 million) in a hybrid angiography suite in 2026. These projects indicate demand across both established and mid-tier European healthcare systems.

Asia-Pacific in the angiography imaging systems market is projected to grow at an 8.11% CAGR through 2032, the fastest regional rate. China, Japan, and India remain central to the region's replacement and first-installation activity. The estimates for the regional DSA installed base, annual replacement rate, Chinese device-industry target, and India's placement growth rate were removed because they relied on ineligible research sources. China is investing in cardiovascular disease management infrastructure at provincial and county hospitals. India's PM-JAY insurance scheme supports tertiary-care catheterization laboratory installation, and AIIMS New Delhi issued a procurement request for a biplane angiographic system in August 2025. The Middle East and Africa remain early-stage markets, while the GCC is positioned as an early technology-adoption area. South American procurement is concentrated in private hospital networks in São Paulo, Buenos Aires, and Bogotá.



List of Companies Covered in this Report:

  1. Abbott Laboratories
  2. AngioDynamics
  3. B. Braun
  4. Boston Scientific
  5. Canon
  6. Cardinal Health
  7. Cordis
  8. Esaote S.p.A.
  9. FUJIFILM
  10. GE Healthcare
  11. Koninklijke Philips
  12. Medtronic
  13. Merit Medical Systems
  14. MicroPort
  15. Mindray
  16. Neusoft
  17. SHIMADZU CORPORATION
  18. Terumo
  19. Ziehm Imaging
  20. Siemens Healthineers

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

Table of Contents

1 Introduction
1.1 Study Assumptions and Market Definition
1.2 Scope of the Study
2 Research Methodology3 Executive Summary
4 Market Landscape
4.1 Market Overview
4.2 Market Drivers
4.2.1 Rising Cardiovascular and Cerebrovascular Disease Burden
4.2.2 Migration Toward Minimally Invasive Image-Guided Procedures
4.2.3 Expansion of Hybrid Operating Rooms and Advanced Cath Labs
4.2.4 AI-Enabled Image Reconstruction and Dose Optimization
4.2.5 Interoperability-Driven Replacement of Legacy Angiography Platforms
4.2.6 Tier-2 and Rural Cath-Lab Deployment in Emerging Markets
4.3 Market Restraints
4.3.1 High Capital, Service, and Room-Conversion Costs
4.3.2 Radiation Exposure and Contrast-Related Clinical Risks
4.3.3 Shortage of Trained Interventional Personnel
4.3.4 Interoperability, Cybersecurity, and Data-Lifecycle Constraints
4.4 Supply Chain Analysis
4.5 Regulatory Landscape
4.6 Technological Outlook
4.7 Porter's Five Forces Analysis
4.7.1 Threat of New Entrants
4.7.2 Bargaining Power of Suppliers
4.7.3 Bargaining Power of Buyers
4.7.4 Threat of Substitutes
4.7.5 Competitive Rivalry
5 Market Size & Growth Forecasts (Value, USD)
5.1 By Technology
5.1.1 X-Ray Angiography
5.1.2 CT Angiography
5.1.3 MRI Angiography
5.1.4 MR-CT Angiography
5.2 By Application
5.2.1 Cardiology
5.2.2 Oncology
5.2.3 Neurology
5.2.4 Peripheral and Vascular Intervention
5.2.5 Other Applications
5.3 By End-User
5.3.1 Hospitals
5.3.2 Ambulatory Surgical Centers
5.3.3 Diagnostic Centers
5.3.4 Other End-Users
5.4 By Geography
5.4.1 North America
5.4.1.1 United States
5.4.1.2 Canada
5.4.1.3 Mexico
5.4.2 Europe
5.4.2.1 Germany
5.4.2.2 United Kingdom
5.4.2.3 France
5.4.2.4 Italy
5.4.2.5 Spain
5.4.2.6 Rest of Europe
5.4.3 Asia-Pacific
5.4.3.1 China
5.4.3.2 Japan
5.4.3.3 India
5.4.3.4 Australia
5.4.3.5 South Korea
5.4.3.6 Rest of Asia-Pacific
5.4.4 Middle East and Africa
5.4.4.1 GCC
5.4.4.2 South Africa
5.4.4.3 Rest of Middle East and Africa
5.4.5 South America
5.4.5.1 Brazil
5.4.5.2 Argentina
5.4.5.3 Rest of South America
6 Competitive Landscape
6.1 Market Concentration
6.2 Market Share Analysis
6.3 Company Profiles (includes Global level Overview, Market level overview, Core Segments, Financials as available, Strategic Information, Market Rank/Share for key companies, Products & Services, Recent Developments)
6.3.1 Abbott Laboratories
6.3.2 AngioDynamics, Inc.
6.3.3 B. Braun Melsungen AG
6.3.4 Boston Scientific Corporation
6.3.5 Canon Medical Systems Corporation
6.3.6 Cardinal Health, Inc.
6.3.7 Cordis
6.3.8 Esaote S.p.A.
6.3.9 FUJIFILM Holdings Corporation
6.3.10 GE HealthCare
6.3.11 Koninklijke Philips N.V.
6.3.12 Medtronic plc
6.3.13 Merit Medical Systems, Inc.
6.3.14 MicroPort Scientific Corporation
6.3.15 Mindray Medical International Limited
6.3.16 Neusoft Medical Systems Co., Ltd.
6.3.17 SHIMADZU CORPORATION
6.3.18 Terumo Corporation
6.3.19 Ziehm Imaging GmbH
6.3.20 Siemens Healthineers AG
7 Market Opportunities & Future Outlook
7.1 White-space & Unmet-need Assessment

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Abbott Laboratories
  • AngioDynamics, Inc.
  • B. Braun Melsungen AG
  • Boston Scientific Corporation
  • Canon Medical Systems Corporation
  • Cardinal Health, Inc.
  • Cordis
  • Esaote S.p.A.
  • FUJIFILM Holdings Corporation
  • GE HealthCare
  • Koninklijke Philips N.V.
  • Medtronic plc
  • Merit Medical Systems, Inc.
  • MicroPort Scientific Corporation
  • Mindray Medical International Limited
  • Neusoft Medical Systems Co., Ltd.
  • SHIMADZU CORPORATION
  • Terumo Corporation
  • Ziehm Imaging GmbH
  • Siemens Healthineers AG